A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to assess the reduction of low-density lipoprotein cholesterol (LDL-C) by SHR-1918 in patients with homozygous familial hypercholesterolemia (HoFH).
Epistemonikos ID: 95904dadcac46d392d03af148fa670c82b122fad
First added on: Jan 01, 2025